Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan

Table 1 Factors pre-disposing a specific Race/Ethnicity for increased risk of coagulopathy

S.No	Race/Ethnicity	Factor V Leiden andprothrombin gene polymorphism [32, 33]	Non-O Blood Group [32, 34]	Lower Protein C levels [32, 35, 36]	High levels of Procoagulant proteins FVIII andvon Willebrand factor [32, 37]	Elevated levels of D-Dimer [32, 38]	Undergoing surgery [32, 39]	Obesity [32, 40]
1	Caucasians/Europeans	High prevalence	High prevalence	High prevalence		High prevalence
2	Afro-Americans	Intermediate prevalence			High prevalence		High prevalence	High prevalence
3	Hispanics					Intermediate prevalence		High prevalence
4	Africans
5	Asians	Low prevalence		High prevalence (Japanese, Taiwanese and Thai)			Low prevalence

ISSN: 1477-9560